Gene · 4057
Papers3,179
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,179
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Abnormal thrombosis and neutrophil activation increase hospital-acquired sacral pressure injuries and morbidity in COVID-19 patients. | Front Immunol | 2023 | 37026002 | PubTator, text mining | PubMed |
| Identification of hub genes and pathways in lung metastatic colorectal cancer. | BMC Cancer | 2023 | 37024866 | PubTator, text mining | PubMed |
| A Hidradenitis Suppurativa molecular disease signature derived from patient samples by high-throughput RNA sequencing and re-analysis of previously reported transcriptomic data sets. | PLoS One | 2023 | 37023004 | PubTator, text mining | PubMed |
| Rac2 regulates immune complex-mediated granule polarization and exocytosis in neutrophils. | J Leukoc Biol | 2023 | 37017007 | PubTator, text mining | PubMed |
| TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia. | Open Med (Wars) | 2023 | 37016705 | PubTator, text mining | PubMed |
| Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis. | Front Endocrinol (Lausanne) | 2023 | 37008925 | PubTator, text mining | PubMed |
| An unbiased proteomics approach to identify the senescence-associated secretory phenotype of human bone marrow-derived mesenchymal stem cells. | Bone Rep | 2023 | 36994454 | PubTator, text mining | PubMed |
| The unfolding story of dying tumor cells during cancer treatment. | Front Immunol | 2023 | 36993986 | PubTator, text mining | PubMed |
| Antibacterial, Anti-Biofilm and Pro-Migratory Effects of Double Layered Hydrogels Packaged with Lactoferrin-DsiRNA-Silver Nanoparticles for Chronic Wound Therapy. | Pharmaceutics | 2023 | 36986852 | PubTator, text mining | PubMed |
| A Review on Dry Eye Disease Treatment: Recent Progress, Diagnostics, and Future Perspectives. | Pharmaceutics | 2023 | 36986851 | PubTator, text mining | PubMed |
| Biomedical Applications of Lactoferrin on the Ocular Surface. | Pharmaceutics | 2023 | 36986726 | PubTator, text mining | PubMed |
| Lactoferrin, Osteopontin and Lactoferrin-Osteopontin Complex: A Critical Look on Their Role in Perinatal Period and Cardiometabolic Disorders. | Nutrients | 2023 | 36986124 | PubTator, text mining | PubMed |
| Scoping Review on Epigenetic Mechanisms in Primary Immune Thrombocytopenia. | Genes (Basel) | 2023 | 36980827 | PubTator, text mining | PubMed |
| PDE3A and GSK3B as Atrial Fibrillation Susceptibility Genes in the Chinese Population via Bioinformatics and Genome-Wide Association Analysis. | Biomedicines | 2023 | 36979891 | PubTator, text mining | PubMed |
| Novel Lactotransferrin-Derived Antimicrobial Peptide LF-1 Inhibits the Cariogenic Virulence Factors of Streptococcus mutans. | Antibiotics (Basel) | 2023 | 36978430 | PubTator, text mining | PubMed |
| The abundances of LTF and SOD2 in amniotic fluid are potential biomarkers of gestational age and preterm birth. | Sci Rep | 2023 | 36966172 | PubTator, text mining | PubMed |
| Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States. | J Crohns Colitis | 2023 | 36961872 | PubTator, text mining | PubMed |
| Proteomic analysis of sialoliths from calcified, lipid and mixed groups as a source of potential biomarkers of deposit formation in the salivary glands. | Clin Proteomics | 2023 | 36949424 | PubTator, text mining | PubMed |
| Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19. | J Clin Immunol | 2023 | 36943669 | PubTator, text mining | PubMed |
| Mass spectrometry-based proteomic profiling of sonicate fluid differentiates Staphylococcus aureus periprosthetic joint infection from non-infectious failure: A pilot study. | Proteomics Clin Appl | 2023 | 36938941 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4057/papers?page=23